Articles
NANS Opens Public Comment on Draft PNS Guideline
The North American Neuromodulation Society (NANS) has opened the public comment period for its draft Clinical Guideline on Implantable Peripheral Nerve Stimulation (PNS) for Chronic Pain—one of the first formal guideline initiatives undertaken by the Society.
NANS Joins Multi-Society Effort on PNS Coverage
The North American Neuromodulation Society (NANS) joined several leading medical specialty societies in submitting joint letters to Cigna Healthcare and UnitedHealthcare regarding policies that classify peripheral nerve stimulation (PNS) as investigational for the treatment of chronic pain.
NANS Joins Multi-Society Comments on Proposed BVN Coverage Policy
The North American Neuromodulation Society (NANS), alongside leading national pain and spine organizations, has submitted a joint comment letter to National Government Services (NGS) regarding its proposed Local Coverage Determination (LCD) for thermal destruction of the intraosseous basivertebral nerve (BVN) to treat vertebrogenic low back pain.
NANS Continues Coverage Advocacy on PNS
As part of its ongoing efforts to protect patient access to evidence-based therapies, NANS has submitted a formal comment letter to Cigna regarding Medical Coverage Policy 0539, which currently classifies Peripheral Nerve Stimulation (PNS) as “not medically necessary.”
WISeR Program Begins January 1, 2026
The WISeR program has released its list of the Model Participants.
What the 2026 Medicare Final Rules Mean for Neuromodulation and Pain Practices
NANS Members: Visit the NANS eLearning platform to download a workbook with full details of how Medicare changes affect neuromodulation, pain, evaluation and management and telemedicine in 2026.
NANS Joins National Effort Urging CMS to Reverse Proposed Limits on Peripheral Nerve Blocks
The North American Neuromodulation Society (NANS) has joined a coalition of national and state medical societies in responding to CMS’ proposed Local Coverage Determinations (LCDs) that would sharply restrict coverage for peripheral nerve blocks (PNBs) and other established chronic pain procedures.
NANS Joins National Push to Rescind Anthem’s New Policy
The North American Neuromodulation Society (NANS) has joined a broad coalition of national medical societies in signing a letter urging Elevance Health (Anthem) to rescind its new Facility Administrative Policy: Use of a Nonparticipating Care Provider, set to take effect January 1, 2026, in 11 states.
NANS 2026 Sets Record Number of Scientific Abstracts — Advancing ‘From Discovery to Healing’
The North American Neuromodulation Society (NANS) has accepted 478 abstract submissions, including 312 scientific abstracts, for its 2026 Annual Meeting, taking place January 22–25, 2026, at Caesars Palace in Las Vegas—the highest number in recent years.
CMS Final Rule Introduces ‘Efficiency’ Cut in 2026 Physician Fee Schedule
The Centers for Medicare & Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (MPFS) Final Rule, effective January 1, 2026, introducing a new –2.5% “efficiency adjustment” that will reduce reimbursement for many surgical and procedural specialties.
NANS Urges Coverage for Peripheral Nerve Stimulation in Chronic Pain
The North American Neuromodulation Society (NANS) has joined seven national medical specialty societies in signing a joint letter urging Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma, and Texas—as well as the Health Care Services Corporation—to revise their draft policy on implantable peripheral nerve stimulation (PNS) for chronic pain.
Physician Action Alert: Protect Access to RFA Procedures & Peripheral Nerve Blocks
Several Medicare Administrative Contractors (MACs) have released proposed Local Coverage Determinations (LCDs) that would classify peripheral nerve blocks and radiofrequency ablation (RFA) procedures—including genicular, shoulder, and hip—as “not reasonable and necessary.”